Mucocutaneous Adverse Events Associated With Oral Sirolimus for the Treatment of Vascular Anomalies.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 33404600.
- Also identified by DOI 10.1001/jamadermatol.2020.5180 and PMC identifier 7788506.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This case series examines the clinical spectrum and frequency of mucocutaneous adverse events related to oral sirolimus in populations with vascular anomalies.
Medical subject headings
- Immunosuppressive Agents
- Mucous Membrane
- Sirolimus
- Skin Diseases